Daiken Medical Co., Ltd. announced non-Consolidated earnings guidance for the year ending March 31, 2021. For the year ending March 31, 2021, on the non-consolidated basis, the company expects, net sales of ¥8,000 million, operating profit of ¥960 million, ordinary profit of ¥1,000 million and profit of ¥710 million or ¥24.71 per share.